Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

84.86
Delayed Data
As of Jul 01
 +1.44 / +1.73%
Today’s Change
77.92
Today|||52-Week Range
120.37
-16.14%
Year-to-Date
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate?
Jul 01 / GuruFocus News - Paid Partner Content
Health Insurers: a Surprising Key to Drugmakers' Sucess
Jun 30 / MotleyFool.com - Paid Partner Content
We've Traded This Stock 11 Times For Income. Let's Do It Again...
Jul 01 / StreetAuthority - Paid Partner Content
3 Dividend Growth Stocks to Buy in July
Jun 30 / MotleyFool.com - Paid Partner Content
141 Reasons to Love Biotech Stocks
Jun 30 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy on Sale Right Now
Jun 29 / MotleyFool.com - Paid Partner Content
5 Top Stocks Investment Guru Joel Greenblatt Would Love
Jun 30 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold
Jun 29 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Gilead, Regulus, AbbVie, The Medicines and GW Phar...
Jun 30 / Zacks.com - Paid Partner Content
Top 6 Research Reports for June 29, 2016
Jun 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close83.42
Today’s open83.15
Day’s range82.75 - 85.30
Volume8,336,302
Average volume (3 months)10,286,703
Market cap$111.1B
Dividend yield2.22%
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-4.19%
Earnings growth (next 5 years)-1.20%
Revenue growth (last year)+28.71%
P/E ratio7.3
Price/Sales4.80
Price/Book6.40

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+2.13+1.40%
BIIBBiogen+3.24+1.34%
BAXBaxter International...+0.23+0.51%
JUNOJuno Therapeutics In...+2.25+5.85%
Data as of 4:14pm ET, 07/01/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$2.99
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs